Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymePreclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitusBradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron.Evolution of the plasma and tissue kallikreins, and their alternative splicing isoformsRole of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential.Genome-wide analysis of gestational gene-environment interactions in the developing kidneyRole of human tissue kallikrein in gastrointestinal stromal tumour invasion.Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science PerspectiveThyroid hormone and COUP-TF1 regulate kallikrein-binding protein (KBP) gene expression.Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates.Human immunodeficiency virus transgenic rats exhibit pulmonary hypertensionTissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.Kinin-B2 receptor activity determines the differentiation fate of neural stem cellsA-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium.Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet.Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stressDevelopment of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling.Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunctionConditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake.Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.Hypertensive crisis in children.From an ACE polymorphism to genome-wide searches for eQTL.2011 and 2012 Early Careers Achievement Awards: Placental programming: how the maternal environment can impact placental function.Unleashing the therapeutic potential of human kallikrein-related serine proteases.Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.Effect of thrombin and bradykinin on endothelial cell mechanical properties monitored through membrane deformation.Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertensionOntogeny of bradykinin B1 receptors in the mouse kidney.Vascular Kinin B1 and B2 Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase.SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway.Vascular reactivity and ACE activity response to exercise training are modulated by the +9/-9 bradykinin B₂ receptor gene functional polymorphism.Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors.Protective effects of histamine on Gq-mediated relaxation in regenerated endothelium.The acute diuretic effect of an ethanolic fraction of Phyllanthus amarus (Euphorbiaceae) in rats involves prostaglandins.Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency
P2860
Q24306614-B11D69C0-5380-4B4F-AB40-DF95D4391CF8Q28541677-1251996E-296F-4898-B0D9-9190B879F1F5Q30467940-B4838D50-45B1-45CA-A132-287A3FE143A2Q31123489-D8B9D215-E102-47B2-81FD-87A0EF6A6F1DQ33649297-7F63FDF5-8136-44FD-942A-18948F34D114Q34131714-4D3C5C8F-9C68-4B24-B8D3-ECE7EEC24CD3Q34344121-B20B5082-21AC-4EEC-8456-82E8FC9EC7E8Q34431996-D1952A8C-589A-4F55-ADEB-D1DA8F380D6EQ34578472-5B9966A5-F9D5-48BE-BD58-AF0A25071FA5Q34695673-E07DCCD4-6984-4B5A-B4CA-CA069A73AAF1Q35217383-0025214D-BF9C-4828-B829-25144398F896Q36147611-5BE3CD17-C89D-47C3-B2D2-FE650A087A4EQ36492736-EB73694F-9FE0-45AB-A1FF-D643DC2FE623Q36540923-1F0DE8FC-4372-40D4-A0C3-AF4450B94BA8Q36682256-D61FC2A4-D663-41B5-81C7-7B0559E38061Q36877892-06A31B06-D461-4E24-AD23-C53FD5175AB7Q37039091-9741958D-B7F3-4AF1-833A-03EB9484513BQ37216578-FB6AC83D-6447-4433-ABFB-E31FB8A2FA95Q37216594-C958FD45-5487-41A8-A433-B377895D888FQ37258096-D9C117D4-3F01-4F0A-89FD-592665E7A704Q37322338-489B3746-C4D2-488C-A6A2-5043F02BB389Q37697808-237D3211-511A-4C2A-9BCB-F434369958C8Q37697813-9DCD2CBE-0C41-49D1-AB65-1EC0D3A01059Q37902972-332EA4B7-35F0-48D7-964A-F1E045CD2604Q38071073-76B45631-A38A-42CB-8776-50B6A67537E2Q38073235-E757FA52-1752-430B-A248-99228D9299D3Q38362486-4764F8A7-839B-4196-BCA2-A848AF30A3E7Q38737293-F1109D9F-BEF2-4712-80C0-261973C9CF91Q39248182-7212195E-D26E-4D14-9E1B-B2E7C0FB43FDQ39735817-AAB7BC2F-264B-41A4-999B-D362C880D99DQ39856778-7DD012DE-0744-4062-BA28-67652E46F193Q41449078-2916640C-F05E-4240-8237-2B4676F18E97Q41963612-05D4A40E-732E-4275-9F0C-9AA135BA677FQ42016385-BBB9CDE1-95BC-4342-AFBA-E4D53ABDC7FFQ44088705-CB61E0BD-1DF4-4032-B59D-3914C9E09426Q45906533-FA8E258F-B1AD-41C6-AF8E-A31606FFA54FQ47776900-AAD5E364-8CA2-44B5-9A54-90C3E8BFD9C9Q54627807-DC47AC87-F9C8-46DA-8B5C-B5EA37ACFB89Q55178051-101C13DC-2843-45D4-9508-B1D0674B79A2Q58586459-A1FEA4A0-57CE-487C-B47E-09252443CACD
P2860
Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms of disease: the tis ...... nsion and vascular remodeling.
@ast
Mechanisms of disease: the tis ...... nsion and vascular remodeling.
@en
type
label
Mechanisms of disease: the tis ...... nsion and vascular remodeling.
@ast
Mechanisms of disease: the tis ...... nsion and vascular remodeling.
@en
prefLabel
Mechanisms of disease: the tis ...... nsion and vascular remodeling.
@ast
Mechanisms of disease: the tis ...... nsion and vascular remodeling.
@en
P2093
P2860
P356
P1476
Mechanisms of disease: the tis ...... nsion and vascular remodeling.
@en
P2093
Costanza Emanueli
Paolo Madeddu
Samir El-Dahr
P2860
P304
P356
10.1038/NCPNEPH0444
P577
2007-04-01T00:00:00Z